Publications by authors named "ZeFei Jiang"

Claim this Profile
E
Effectiveness and safety of acupuncture therapies for intractable hiccups: a systematic review and network meta-analysis.
Yan Zhai, You-Yi Hui, Ze-Fei Jiang, Guang Liu, Lin Ding

Front Med (Lausanne)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial.
Yongmei Yin, Qingyuan Zhang, Tao Sun, Chunfang Hao, Zhihong Wang, Yunjiang Liu, Zefei Jiang

Signal Transduct Target Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of MRG002 monotherapy in treating patients with locally advanced or metastatic breast cancer with low HER2 expression: A multi-center, non-randomized, open-label phase II clinical trial.
Shaohua Zhang, Tao Sun, Xiaojia Wang, Min Yan, Qiang Liu, Zefei Jiang

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of new immunomodulatory drugs on major adverse cardiovascular events in patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials.
Donghang He, Yuhan Li, Zefei Jiang, Xin Cao, Rong Luo

BMC Cardiovasc Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring upstream and downstream causality of inflammatory cytokines in intervertebral disc degeneration: a bidirectional, two-sample Mendelian randomization study.
Pan Huang, Yi He, Na Zhi, Wenqi Yi, Caixia Guo, ZeFei Jiang

Eur Spine J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.
Sara M Tolaney, Zefei Jiang, Qingyuan Zhang, Romualdo Barroso-Sousa, Yeon Hee Park

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Survival Outcomes in Metastatic Triple Negative Breast Cancer: Immunotherapy- Versus Anti-Angiogenic Therapy-Combined-With-Chemotherapy.
Yingzhe Wang, Song Wu, Jianbin Li, Yang Yuan, Li Bian, Zefei Jiang

Cancer Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a prognostic risk stratification model for HER2-positive breast cancer brain metastasis and its implications in guiding treatment decisions.
Jiaxin Chen, Yuan Sh, Danfeng Dong, Huicui Yan, Huiqiang Zhang, Zefei Jiang

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of trastuzumab deruxtecan in heavily pre-treated HER2-low metastatic breast cancer across distinct immunohistochemistry statuses.
Song Wu, Jianbin Li, Li Bian, Siyuan Zhang, Shaohua Zhang, Zefei Jiang

Transl Breast Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DESTINY-Breast09, new breakthroughs in first-line therapy for HER2-positive advanced breast cancer.
Jianbing Li, Chunfang Hao, Haibo Wang, Yueyin Pan, Zefei Jiang

Transl Breast Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese expert consensus on clinical diagnosis and treatment of breast cancer targeting HER2.
Jianbin Li, Yueping Liu, Shu Wang, Shusen Wang, Shaohua Zhang, Zefei Jiang

Transl Breast Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2- advanced breast cancer: Final results of the randomized phase III MONARCH plus trial.
Xichun Hu, Qingyuan Zhang, Tao Sun, Yongmei Yin, Huiping Li, Zefei Jiang

Chin Med J (Engl)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.
Wolfgang Janni, Thomas W P Friedl, Tracy C Yab, Francois-Clément Bidard, Massimo Cristofanilli, Zefei Jiang

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of trastuzumab deruxtecan in HER2-positive breast cancer patients with brain metastases after failure of pyrotinib-based therapy.
Jinmei Zhou, Jinyi Xiao, Xuexue Wu, Xiaobo Wang, Li Bian, Zefei Jiang

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancer.
Zefei Jiang, Quchang Ouyang, Tao Sun, Qingyuan Zhang, Yuee Teng

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel anti-HER2 ADCs vs dual anti-HER2 antibody for HER2-positive metastatic breast cancer failed to tyrosine kinase inhibitor.
Feng Li, Jianbin Li, Chenchen Ji, Song Wu, Shaohua Zhang, Zefei Jiang

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of wet cupping in the treatment of neurodermatitis: a systematic review and meta-analysis.
Yan Zhai, You-Yi Hui, Ze-Fei Jiang, Lin Ding, Jie Cheng

Front Med (Lausanne)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China.
Jianbin Li, Zefei Jiang

Cancer Biol Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2-, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study.
Qingyuan Zhang, Kunwei Shen, Chuan-Gui Song, Quchang Ouyang, Zhenzhen Liu, Zefei Jiang

Ther Adv Med Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Identification of oxidative stress-related diagnostic markers and immune infiltration features for idiopathic pulmonary fibrosis by bibliometrics and bioinformatics.
Chang Li, Qing An, Yi Jin, Zefei Jiang, Meihe Li

Front Med (Lausanne)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of Acupuncture Combined With Modified Blood and Vessel Expelling Blood Stasis Tang in Treating Poststroke Facial Paralysis With Insomnia.
Ran Sun, Zefei Jiang, Yiming Sun

J Craniofac Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stellate ganglion, inflammation, and arrhythmias: a new perspective on neuroimmune regulation.
Qiulian Lei, Zefei Jiang, Yu Shao, Xinghong Liu, Xiaoping Li

Front Cardiovasc Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China.
Song Wu, Li Bian, Haibo Wang, Shaohua Zhang, Tao Wang, Zefei Jiang

World J Surg Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of oxidative stress-related diagnostic markers and immune infiltration features for idiopathic pulmonary fibrosis by bibliometrics and bioinformatics.
Chang Li, Qing An, Yi Jin, Zefei Jiang, Meihe Li

Front Med (Lausanne)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024.
Jianbin Li, Chunfang Hao, Kun Wang, Jian Zhang, Jiayi Chen, Zefei Jiang

Transl Breast Cancer Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis